Breast disorders

Guidelines (7)

Everolimus in Combination with Exemestane for Treating Advanced HER2-Negative Hormone-Receptor-Positive Breast Cancer after Endocrine Therapy (TA295)

28 August 2013

Bevacizumab in Combination with Capecitabine for the First-Line Treatment of Metastatic Breast Cancer (TA263)

24 August 2012

Lapatinib or Trastuzumab in Combination with an Aromatase Inhibitor for the First-Line Treatment of Metastatic Hormone-Receptor-Positive Breast Cancer that Overexpresses HER2 (TA257)

27 July 2012

Eribulin for the Treatment of Locally Advanced or Metastatic Breast Cancer (TA250)

23 April 2012

Bevacizumab in Combination with a Taxane for the First-Line Treatment of Metastatic Breast Cancer (TA214)

17 March 2011

Cancer, Breast (Early): Hormonal Therapies (NICE)

4 October 2007

Cancer, Breast (Metastatic): Gemcitabine (NICE)

3 October 2007

Drug Sections (1)

Breast disorders in the News

Kadcyla: a new option in locally advanced or metastatic breast cancer

Kadcyla: a new option in locally advanced or metastatic breast cancer

2 January 2014

Kadcyla (trastuzumab emtansine) is indicated in HER2-positive,...

Herceptin now available for subcutaneous injection

Herceptin now available for subcutaneous injection

1 November 2013

A subcutaneous formulation of the breast cancer treatment...

All Women's Health Patient Fact Sheets

5 March 2007

Printable fact sheets providing your female patients...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter  

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more